Behind the huge and scary numbers that accompany the costs of drug development, there are various holes and dysfunctional practices in the process of bringing a new drug to market.
Fresh off raising $12 million in Series B financing, goBalto has lured a major CRO with its cloud-based clinical development platform, signing a deal with INC Research.
INC Research is boosting its presence in South Korea with a new clinical development facility, citing the country's recent progress in supporting the biopharmaceutical industry.
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant ( email | Twitter ) and Nesa Nourmohammadi (...
The North Carolina CRO announced that Chief Operating Officer Jamie Macdonald will assume the role of CEO beginning next year, marking one of three C-level promotions within the company.
INC is facing another facility closure. Its clinical study unit in Morgantown, WV will be shut down, according to a story by The State Journal .
The American CRO and the Japanese pharma star entered a three-year, functional service provider (FSP) alliance that kicked off earlier this month.
INC Research will let go of 66 employees from its facility in Old Lyme, CT, which will close this summer.
Over the past few years the clinical research organization side of the industry has been undergoing a steady shakeout of small players as the big CROs lined up long-term deals with drug developers....
Determined to vault into the top tier of the global CRO business, INC Research has struck a deal to buy out Kendle ( $KNDL ) for $232 million in cash. The deal gives INC global Phase I-IV operations